» Articles » PMID: 37020057

Culturally and Linguistically Diverse Patients' Perspectives and Experiences on Medicines Management in Australia: a Systematic Review

Overview
Publisher Springer
Specialties Pharmacology
Pharmacy
Date 2023 Apr 5
PMID 37020057
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Within the quality use of medicines (QUM)-which entails timely access to, and the rational use of, medicines-medicine safety is a global health priority. In multicultural countries, such as Australia, national medicines policies are focused on achieving QUM, although this is more challenging among their Culturally and Linguistically Diverse (CALD) patients (i.e., those from ethnic minority groups).

Aim: This review aimed to identify and explore the specific challenges to achieving QUM, as experienced by CALD patients living in Australia.

Method: A systematic literature search was conducted using Web of Science, Scopus, Academic search complete, CINHAL, PubMed and Medline. Qualitative studies describing any aspects of QUM among CALD patients in Australia were included.

Results: Major challenges in facilitating QUM among CALD patients in Australia were identified, particularly in relation to the following medicines management pathway steps: difficulties around participation in treatment decision-making alongside deficiencies in information provision about medicines. Furthermore, medication non-adherence was commonly observed and reported. When mapped against the bio-psycho-socio-systems model, the main contributors to the medicine management challenges identified related to "social" and "system" factors, reflecting the current health-system's lack of capacity and resourcing to respond to patients' low health literacy levels, communication and language barriers, and cultural and religious perceptions about medicines.

Conclusion: QUM challenges were different among different ethnic groups. This review suggests a need to engage with CALD patients in co-designing culturally appropriate resources and/or interventions to enable the health-system to address the identified barriers to QUM.

Citing Articles

Quality and safety issue: language barriers in healthcare, a qualitative study of non-Arab healthcare practitioners caring for Arabic patients in the UAE.

Al-Yateem N, Hijazi H, Saifan A, Ahmad A, Masadeh R, Alrimawi I BMJ Open. 2023; 13(12):e076326.

PMID: 38135338 DOI: 10.1136/bmjopen-2023-076326.


Healthcare Providers' Attitudes and Experiences of the Quality Use of Medications Among Culturally and Linguistically Diverse Patients in Australia: A Systematic Review of Qualitative Studies.

Sawalha R, Hosseinzadeh H, Bajorek B J Immigr Minor Health. 2023; 26(1):181-199.

PMID: 37428280 DOI: 10.1007/s10903-023-01522-0.


Development and validation of a Medication Adherence Universal Questionnaire: the MAUQ.

Cabral A, Lavrador M, Castel-Branco M, Figueiredo I, Fernandez-Llimos F Int J Clin Pharm. 2023; 45(4):999-1006.

PMID: 37329432 PMC: 10366321. DOI: 10.1007/s11096-023-01612-x.

References
1.
McLachlan A, Aslani P . National Medicines Policy 2.0: a vision for the future. Aust Prescr. 2020; 43(1):24-26. PMC: 7026915. DOI: 10.18773/austprescr.2020.007. View

2.
Chauhan A, Walton M, Manias E, Walpola R, Seale H, Latanik M . The safety of health care for ethnic minority patients: a systematic review. Int J Equity Health. 2020; 19(1):118. PMC: 7346414. DOI: 10.1186/s12939-020-01223-2. View

3.
Pham T, Berecki-Gisolf J, Clapperton A, OBrien K, Liu S, Gibson K . Definitions of : A Literature Review of Epidemiological Research in Australia. Int J Environ Res Public Health. 2021; 18(2). PMC: 7830035. DOI: 10.3390/ijerph18020737. View

4.
Schwappach D, Meyer Massetti C, Gehring K . Communication barriers in counselling foreign-language patients in public pharmacies: threats to patient safety?. Int J Clin Pharm. 2012; 34(5):765-72. DOI: 10.1007/s11096-012-9674-7. View

5.
Herrera H, Alsaif M, Khan G, Barnes N, Rutter P . Provision of Bilingual Dispensing Labels to Non-Native English Speakers: An Exploratory Study. Pharmacy (Basel). 2019; 7(1). PMC: 6473342. DOI: 10.3390/pharmacy7010032. View